المؤلفون: Hellmann, Matthew, Paz-Ares, Luis, Bernabe Caro, Reyes, Zurawski, Bogdan, Kim, Sang-We, Carcereny Costa, Enric, Park, Keunchil, Alexandru, Aurelia, Lupinacci, Lorena, de La Mora Jimenez, Emmanuel, Sakai, Hiroshi, Albert, Istvan, Vergnenègre, Alain, Peters, Solange, Syrigos, Konstantinos, Barlesi, Fabrice, Reck, Martin, Borghaei, Hossein, Brahmer, Julie, O'Byrne, Kenneth, Geese, William, Bhagavatheeswaran, Prabhu, Rabindran, Sridhar, Kasinathan, Ravi, Nathan, Faith, Ramalingam, Suresh, O’byrne, Kenneth

المساهمون: Samsung Medical Center Sungkyunkwan University School of Medicine, Institute Division of Hematology/Oncology, Bioinformatics Consulting Center, Pennsylvania State University (Penn State), Penn State System-Penn State System, Service de Pathologie respiratoire et allergologie [CHU Limoges], CHU Limoges, Centre Hospitalier Universitaire Vaudois [Lausanne] (CHUV), National and Kapodistrian University of Athens (NKUA), Assistance Publique - Hôpitaux de Marseille (APHM), Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), AstraZeneca, Bristol-Myers Squibb, Ono Pharmaceutical

المصدر: New England Journal of Medicine
r-IGTP: Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
New England Journal of Medicine, 2019, 381 (21), pp.2020-2031. ⟨10.1056/NEJMoa1910231⟩
Digital.CSIC. Repositorio Institucional del CSIC
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
New England Journal of Medicine, Massachusetts Medical Society, 2019, 381 (21), pp.2020-2031. ⟨10.1056/NEJMoa1910231⟩

مصطلحات موضوعية: Oncology, Male, Lung Neoplasms, [SDV]Life Sciences [q-bio], 030204 cardiovascular system & hematology, B7-H1 Antigen, law.invention, MESH: Ipilimumab, 0302 clinical medicine, Antineoplastic Agents, Immunological, MESH: Aged, 80 and over, Randomized controlled trial, law, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, MESH: B7-H1 Antigen, 030212 general & internal medicine, Response rate (survey), Aged, 80 and over, MESH: Aged, MESH: Middle Aged, General Medicine, Middle Aged, 3. Good health, MESH: Antineoplastic Combined Chemotherapy Protocols, Nivolumab, MESH: Survival Analysis, MESH: Nivolumab, Female, medicine.drug, Adult, medicine.medical_specialty, Ipilimumab, [SDV.BC]Life Sciences [q-bio]/Cellular Biology, 03 medical and health sciences, Internal medicine, Carcinoma, medicine, Humans, Lung cancer, Survival analysis, Aged, MESH: Humans, business.industry, MESH: Adult, medicine.disease, Survival Analysis, MESH: Antineoplastic Agents, Immunological, MESH: Male, respiratory tract diseases, MESH: Lung Neoplasms, Clinical trial, business, MESH: Female, MESH: Carcinoma, Non-Small-Cell Lung

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18ad09d5c956f063b752bce70429dbbbTest
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1330Test

المؤلفون: Jung, Kyung Hae, LoRusso, Patricia, Burris, Howard, Gordon, Michael, Bang, Yung-Jue, Hellmann, Matthew, Cervantes, Andres, de Olza, Maria Ochoa, Marabelle, Aurélien, Hodi, F Stephen, Ahn, Myung-Ju, Emens, Leisha, Barlesi, Fabrice, Hamid, Omid, Calvo, Emiliano, McDermott, David, Soliman, Hatem, Rhee, Ina, Lin, Ray, Pourmohamad, Tony, Suchomel, Julia, Tsuhako, Amy, Morrissey, Kari, Mahrus, Sami, Morley, Roland, Pirzkall, Andrea, Davis, S Lindsey, Hodi, F. Stephen, Davis, S. Lindsey

المساهمون: Karmanos Cancer Institute (Detroit), Universitat de València (UV), Equipe 11, Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM), Tumor Immunology and Breast Cancer Research Programs, Johns Hopkins University School of Medicine, Assistance Publique - Hôpitaux de Marseille (APHM), Centre de Recherche en Cancérologie de Marseille (CRCM), Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Aix Marseille Université (AMU), Cedars-Sinai Medical Center, Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Clinical Cancer Research
Clinical Cancer Research, American Association for Cancer Research, 2019, 25 (11), pp.3220-3228. ⟨10.1158/1078-0432.CCR-18-2740⟩
Clinical Cancer Research, 2019, 25 (11), pp.3220-3228. ⟨10.1158/1078-0432.CCR-18-2740⟩
Clin Cancer Res

مصطلحات موضوعية: 0301 basic medicine, Adult, Cancer Research, Indoles, [SDV]Life Sciences [q-bio], [SDV.BC]Life Sciences [q-bio]/Cellular Biology, Pharmacology, Antibodies, Monoclonal, Humanized, Article, B7-H1 Antigen, 03 medical and health sciences, 0302 clinical medicine, Pharmacokinetics, Atezolizumab, Renal cell carcinoma, Neoplasms, Antineoplastic Combined Chemotherapy Protocols, medicine, Biomarkers, Tumor, Humans, Indoleamine-Pyrrole 2,3,-Dioxygenase, Neoplasm Metastasis, Aged, Neoplasm Staging, Aged, 80 and over, Bladder cancer, business.industry, Melanoma, Imidazoles, Middle Aged, medicine.disease, Magnetic Resonance Imaging, 3. Good health, 030104 developmental biology, Treatment Outcome, Oncology, Tolerability, 030220 oncology & carcinogenesis, Pharmacodynamics, PD-L1 inhibitor, business, Tomography, X-Ray Computed

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97784b8a4ed5b767c2db064581ed9c52Test
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=2838Test